Amneal denied summary judgment against US states’ antitrust case over Phenytoin
Amneal Pharmaceuticals’ motion for judgment against claims it fixed prices has been denied, but the US states and territories suing the company must now focus on alleging Amneal carried out a...To view the full article, register now.
Already a subscriber? Click here to view full article